Literature DB >> 17374543

A prospective study assessing the utility of Cogan's lid twitch sign in patients with isolated unilateral or bilateral ptosis.

Gregory P Van Stavern1, Aash Bhatt, James Haviland, Evan H Black.   

Abstract

OBJECTIVE: Cogan's lid twitch is thought to suggest myasthenia gravis in patients with unexplained ptosis. The validity of this clinical test has not been established. We conducted a prospective study to ascertain the sensitivity and specificity of this finding.
METHODS: 35 patients with isolated, symptomatic ptosis, referred to a neuro-ophthalmologist or oculoplastics specialist were enrolled. The presence or absence of Cogan's lid twitch was noted, according to standard technique. Further testing was performed, and the final diagnosis for each patient was recorded.
RESULTS: Four patients were found to have a Cogan's lid twitch. Two patients had ocular myasthenia gravis as the final diagnosis, and of those, only one had a twitch.
CONCLUSIONS: The sensitivity and specificity of Cogan's lid twitch is relatively low. Other conditions may cause a lid twitch as well. The presence of a Cogan's lid twitch may increase suspicion of myasthenia, but is not diagnostic, and does not exclude alternate etiologies of ptosis.

Entities:  

Mesh:

Year:  2007        PMID: 17374543     DOI: 10.1016/j.jns.2007.02.020

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  3 in total

Review 1.  Selected lid problems in neurologic practice.

Authors:  Gregory S Kosmorsky; Alyssa Fiddler
Journal:  Curr Neurol Neurosci Rep       Date:  2009-09       Impact factor: 5.081

2.  Validity of Forced Eyelid Closure Test: A Novel Clinical Screening Test for Ocular Myasthenia Gravis.

Authors:  Supanut Apinyawasisuk; Xinkai Zhou; Jack J Tian; Giancarlo A Garcia; Rustum Karanjia; Alfredo A Sadun
Journal:  J Neuroophthalmol       Date:  2017-09       Impact factor: 4.415

3.  A Challenging Case of Eyelid Ptosis and Diplopia Induced by Pembrolizumab.

Authors:  Daniela Garcez; Ana Isabel Clara; Maria Francisca Moraes-Fontes; José Bravo Marques
Journal:  Cureus       Date:  2022-08-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.